[go: up one dir, main page]

BRPI0417205A - composições farmacêuticas - Google Patents

composições farmacêuticas

Info

Publication number
BRPI0417205A
BRPI0417205A BRPI0417205-1A BRPI0417205A BRPI0417205A BR PI0417205 A BRPI0417205 A BR PI0417205A BR PI0417205 A BRPI0417205 A BR PI0417205A BR PI0417205 A BRPI0417205 A BR PI0417205A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
disclosed
useful pharmaceutical
compositions
pharmaceutical
Prior art date
Application number
BRPI0417205-1A
Other languages
English (en)
Inventor
Susan K Heimbecher
Jim H Kou
Irina Kazakevich
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BRPI0417205A publication Critical patent/BRPI0417205A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PATENTE DE INVENçãO: "COMPOSIçãO FARMACEUTICAS". Descritas são composições farmacêuticas úteis.
BRPI0417205-1A 2003-12-19 2004-12-17 composições farmacêuticas BRPI0417205A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53156103P 2003-12-19 2003-12-19
PCT/US2004/042616 WO2005060981A2 (en) 2003-12-19 2004-12-17 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BRPI0417205A true BRPI0417205A (pt) 2007-02-06

Family

ID=34710234

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417205-1A BRPI0417205A (pt) 2003-12-19 2004-12-17 composições farmacêuticas

Country Status (15)

Country Link
US (3) US20060009504A1 (pt)
EP (1) EP1701699B1 (pt)
JP (1) JP2007514758A (pt)
KR (1) KR20060111581A (pt)
CN (1) CN100528162C (pt)
AT (1) ATE516011T1 (pt)
AU (1) AU2004303425C1 (pt)
BR (1) BRPI0417205A (pt)
CA (1) CA2550071A1 (pt)
MX (1) MXPA06007102A (pt)
NO (1) NO20063293L (pt)
NZ (1) NZ547557A (pt)
PL (1) PL380665A1 (pt)
WO (1) WO2005060981A2 (pt)
ZA (1) ZA200604874B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2528631T3 (es) 2003-04-08 2015-02-11 Progenics Pharmaceuticals, Inc. Formulaciones farmacéuticas que contienen metilnaltrexona
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
US20090041839A1 (en) * 2007-05-23 2009-02-12 Beasley Martin W Pharmaceutical compositions for the treatment of pain
SE531698C2 (sv) 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider
MA34146B1 (fr) 2010-03-11 2013-04-03 Wyeth Llc Formulations oralles et sels lipophiles de methylnaltrexone
WO2012127472A1 (en) * 2011-03-22 2012-09-27 Mapi Pharma Ltd. Process and intermediates for the preparation of preladenant and related compounds
CN106365221B (zh) * 2016-11-09 2019-04-19 烟台史密得机电设备制造有限公司 一种金刚烷单季铵盐阳离子型三元复合驱采出水除油剂
BR112019023249A8 (pt) 2017-05-05 2021-02-23 Centre For Probe Dev And Commercialization anticorpos monoclonais igf-1r e usos dos mesmos
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
IL270453B2 (en) 2017-05-05 2025-05-01 Fusion Pharmaceuticals Inc Pharmacokinetic enhancements of bifunctional chelates and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656028A (en) * 1986-06-24 1987-04-07 Norcliff Thayer Inc. Encapsulated antacid
US5935584A (en) * 1994-01-13 1999-08-10 Elizabeth Arden Company Vitamin C delivery system
PT901786E (pt) * 1997-08-11 2007-08-07 Pfizer Prod Inc Disperções farmacêuticas sólidas com biodisponibilidade melhorada
US6326390B1 (en) * 1998-08-25 2001-12-04 King Pharmaceuticals Reseach And Development, Inc. Use of adenosine A3 receptor antagonists to inhibit tumor growth
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
US6921825B2 (en) * 1998-09-16 2005-07-26 King Pharmaceuticuals Research & Development, Inc. Adenosine A3 receptor modulators
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
JP2003500368A (ja) * 1999-05-24 2003-01-07 ソーナス ファーマシューティカルス，インコーポレイテッド 溶解度が不十分な薬剤のためのエマルジョンビヒクル
JP4100865B2 (ja) * 1999-12-13 2008-06-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 三環式縮合異項環化合物、その製造法およびその医薬
MXPA02011625A (es) * 2000-05-26 2003-03-27 Schering Corp Antagonistas receptores de adenosina a2a.
AR037243A1 (es) * 2001-10-15 2004-11-03 Schering Corp Antagonistas del receptor de adenosina a2a,a5-amino-imidazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]pirimidina, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
ATE453647T1 (de) * 2001-11-30 2010-01-15 Schering Corp Adenosin a2a rezeptor antagonisten
HK1082662A1 (zh) * 2002-05-30 2006-06-16 King Pharmaceuticals Research And Development Inc. 具有三环吡唑并三唑并嘧啶环结构的制药活性化合物及其使用方法
US6982253B2 (en) * 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same

Also Published As

Publication number Publication date
EP1701699B1 (en) 2011-07-13
MXPA06007102A (es) 2006-08-23
NO20063293L (no) 2006-07-14
EP1701699A2 (en) 2006-09-20
NZ547557A (en) 2010-07-30
PL380665A1 (pl) 2007-03-05
WO2005060981A3 (en) 2005-12-29
AU2004303425A1 (en) 2005-07-07
US20060009504A1 (en) 2006-01-12
KR20060111581A (ko) 2006-10-27
AU2004303425B2 (en) 2009-03-26
CA2550071A1 (en) 2005-07-07
ZA200604874B (en) 2007-03-28
CN100528162C (zh) 2009-08-19
JP2007514758A (ja) 2007-06-07
CN1893921A (zh) 2007-01-10
WO2005060981A2 (en) 2005-07-07
AU2004303425C1 (en) 2010-02-18
US20080293734A1 (en) 2008-11-27
US20110207740A1 (en) 2011-08-25
ATE516011T1 (de) 2011-07-15

Similar Documents

Publication Publication Date Title
LTC1608344I2 (lt) Per burną vartojamos kladribino kompozicijos
DE602004021120D1 (de) Photopolymerisierbare zusammensetzung.
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
NO20044597L (no) Kjemiske forbindelser
NO20074037L (no) Farmasoytiske formuleringer med vedvarende frigivelse
FR2862654B1 (fr) Composition amylacee filmogene
DE60311307D1 (de) Shampoo-zusammensetzungen
DE10393374D2 (de) Zusammensetzung
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DK1587478T3 (da) Farmaceutisk sammensætning
DK1615640T3 (da) Antineoplastiske sammensætninger
IS8309A (is) Lyfjablöndur
DE60316954D1 (de) Shampoozusammensetzungen
DK1492934T3 (da) Dørenhed
DE602004004388D1 (de) Verdickbare zusammensetzungen
NO20063393L (no) Farmasoytiske preparater
SE0301650D0 (sv) Novel compounds
SE0500163L (sv) Sammansättning
BRPI0417205A (pt) composições farmacêuticas
DK1646425T3 (da) Parasitisk sammensætning
EP1561467A4 (en) COMPOSITION FOR RECOVERING DAMAGED SKIN
FR2861290B1 (fr) Composition cosmetique thermogonflante.
ATE365529T1 (de) Schweisshemmende zusammensetzungen
NL1025908A1 (nl) Farmaceutische combinatie.
NO20044164L (no) Farmasoytiske sammensetninger

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 9/00, 9/48, 31/505; A61P 25/16

Ipc: A61K 9/00 (2011.01), A61K 9/48 (2011.01), A61K 31/

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.